In vivo zebrafish assays for analyzing drug toxicity

Introduction: Off-target effects represent one of the major concerns in the development of new pharmaceuticals, requiring large-scale animal toxicity testing. Faster, cheaper and more reliable assays based on zebrafish embryos (ZE) are being developed as major tools for assessing toxicity of chemicals during the drug-discovery process. Areas covered: This paper reviews techniques aimed to the analysis of in vivo sublethal toxic effects of drugs on major physiological functions, including the cardiovascular, nervous, neuromuscular, gastrointestinal and thyroid systems among others. Particular emphasis is placed on high-throughput screening techniques (HTS), including robotics, imaging technologies and image-analysis software. Expert opinion: The analysis of off-target effects of candidate drugs requires systemic analyses, as they often involve the complete organism rather than specific, tissue- or cell-specific targets. The unique physical and physiological characteristics of ZE make this system an essential tool for drug discovery and toxicity assessment. Different HTS methodologies applicable to ZE allow the screening of large numbers of different chemicals for many diverse and relevant toxic endpoints.

[1]  Zuoyan Zhu,et al.  Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. , 2008, Developmental biology.

[2]  C. Seiler,et al.  Defective calmodulin-dependent rapid apical endocytosis in zebrafish sensory hair cell mutants. , 1999, Journal of neurobiology.

[3]  Merle G Paule,et al.  Ketamine induces motor neuron toxicity and alters neurogenic and proneural gene expression in zebrafish , 2013, Journal of applied toxicology : JAT.

[4]  Wei Huang,et al.  The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. , 2009, American heart journal.

[5]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[6]  M. Fishman,et al.  Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Tsui,et al.  Nobiletin, a polymethoxylated flavonoid from citrus, shows anti‐angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model , 2011, Journal of cellular biochemistry.

[8]  F. Van de Werf,et al.  Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). , 2010, European heart journal.

[9]  M. Halpern,et al.  Characterization of myelination in the developing zebrafish , 2002, Glia.

[10]  Caroline E. Burns,et al.  Tbx1 is required for second heart field proliferation in zebrafish , 2013, Developmental dynamics : an official publication of the American Association of Anatomists.

[11]  Didier Y. R. Stainier,et al.  Zebrafish genetics and vertebrate heart formation , 2001, Nature Reviews Genetics.

[12]  C. Hornuss,et al.  Pharmacologic management of postoperative nausea and vomiting , 2011, Expert opinion on pharmacotherapy.

[13]  M. Ekker,et al.  Transgenic zebrafish expressing green fluorescent protein in dopaminergic neurons of the ventral diencephalon , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  Raphaël Marée,et al.  Automated processing of zebrafish imaging data: a survey. , 2013, Zebrafish.

[15]  Paul Goldsmith,et al.  Zebrafish as a pharmacological tool: the how, why and when. , 2004, Current opinion in pharmacology.

[16]  K. Eagle,et al.  Medication performance measures and mortality following acute coronary syndromes. , 2005, American Journal of Medicine.

[17]  Michael J. Parsons,et al.  Automated Reporter Quantification In Vivo: High-Throughput Screening Method for Reporter-Based Assays in Zebrafish , 2012, PloS one.

[18]  R. Califf,et al.  Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. , 2006, Archives of internal medicine.

[19]  B. Piña,et al.  Triiodothyronine-induced changes in the zebrafish transcriptome during the eleutheroembryonic stage: implications for bisphenol A developmental toxicity. , 2012, Aquatic toxicology.

[20]  Timo Friedrich,et al.  Macondo crude oil from the Deepwater Horizon oil spill disrupts specific developmental processes during zebrafish embryogenesis , 2012, BMC Biology.

[21]  Miguel M Santos,et al.  How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria‐targeted drugs , 2013, British journal of pharmacology.

[22]  H. Krause,et al.  The zebrafish: a powerful platform for in vivo, HTS drug discovery. , 2011, Assay and drug development technologies.

[23]  C. Wen,et al.  Movement disorder and neuromuscular change in zebrafish embryos after exposure to caffeine. , 2008, Neurotoxicology and teratology.

[24]  A. Schier,et al.  Hematopoietic mutations in the zebrafish. , 1996, Development.

[25]  A. Roach,et al.  Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery , 2008, British journal of pharmacology.

[26]  O. Kah,et al.  A cyp19a1b‐gfp (aromatase B) transgenic zebrafish line that expresses GFP in radial glial cells , 2009, Genesis.

[27]  Christian Laggner,et al.  Rapid behavior—based identification of neuroactive small molecules in the zebrafish , 2009, Nature chemical biology.

[28]  D. Lyons,et al.  Dissecting mechanisms of myelinated axon formation using zebrafish. , 2011, Methods in cell biology.

[29]  Tao Chen,et al.  Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives , 2012, Molecules.

[30]  Jen-Leih Wu,et al.  In vivo studies of liver‐type fatty acid binding protein (L‐FABP) gene expression in liver of transgenic zebrafish (Danio rerio) , 2003, FEBS letters.

[31]  J. M. Turner,et al.  Zebrafish puma mutant decouples pigment pattern and somatic metamorphosis. , 2003, Developmental biology.

[32]  C. Ton,et al.  The use of zebrafish for assessing ototoxic and otoprotective agents , 2005, Hearing Research.

[33]  P. Ingham,et al.  Expression of multiple slow myosin heavy chain genes reveals a diversity of zebrafish slow twitch muscle fibres with differing requirements for Hedgehog and Prdm1 activity , 2008, Development.

[34]  M. Halpern,et al.  Androgen receptor gene expression in the developing and adult zebrafish brain , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  Yau-Hung Chen,et al.  Treatment with sodium benzoate leads to malformation of zebrafish larvae. , 2007, Neurotoxicology and teratology.

[36]  A. Kanthasamy,et al.  Measurement of proteasomal dysfunction in cell models of dopaminergic degeneration. , 2011, Methods in molecular biology.

[37]  Yi Zhou,et al.  Activated N-Ras signaling regulates arterial-venous specification in zebrafish , 2013, Journal of Hematology & Oncology.

[38]  D. Stainier,et al.  Formation of the digestive system in zebrafish: III. Intestinal epithelium morphogenesis. , 2005, Developmental biology.

[39]  S. Haggarty,et al.  Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation , 2010, Science.

[40]  Demetrio Raldúa,et al.  Zebrafish eleutheroembryos provide a suitable vertebrate model for screening chemicals that impair thyroid hormone synthesis. , 2011, Environmental science & technology.

[41]  Donald Wlodkowic,et al.  Toward embedded laboratory automation for smart Lab-on-a-Chip embryo arrays. , 2013, Biosensors & bioelectronics.

[42]  Ting-Shuan Wu,et al.  Cardiotoxicity of mycotoxin citrinin and involvement of microRNA-138 in zebrafish embryos. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  Patricia McGrath,et al.  Zebrafish: a predictive model for assessing drug-induced toxicity. , 2008, Drug discovery today.

[44]  Xiaoyin Xu,et al.  A High-Throughput Analysis Method to Detect Regions of Interest and Quantify Zebrafish Embryo Images , 2010, Journal of biomolecular screening.

[45]  J. Cata,et al.  Management of chemotherapy-induced peripheral neuropathy , 2006, Current pain and headache reports.

[46]  M. J. Hemmer,et al.  Optimization of whole-body zebrafish sectioning methods for mass spectrometry imaging. , 2013, Journal of biomolecular techniques : JBT.

[47]  Xiaoyin Xu,et al.  Automated analysis of zebrafish images for phenotypic changes in drug discovery , 2011, Journal of Neuroscience Methods.

[48]  Lixin Yang,et al.  Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryo , 2007, Genome Biology.

[49]  V. Delov,et al.  The classification of motor neuron defects in the zebrafish embryo toxicity test (ZFET) as an animal alternative approach to assess developmental neurotoxicity. , 2012, Neurotoxicology and teratology.

[50]  W. Richardson,et al.  A screen for mutations in zebrafish that affect myelin gene expression in Schwann cells and oligodendrocytes. , 2006, Developmental biology.

[51]  W. Heideman,et al.  Zebrafish and cardiac toxicology , 2007, Cardiovascular Toxicology.

[52]  Donald R Love,et al.  Technology for high-throughput screens: the present and future using zebrafish. , 2004, Current opinion in biotechnology.

[53]  L. Zon,et al.  In vivo drug discovery in the zebrafish , 2005, Nature Reviews Drug Discovery.

[54]  J. Davison,et al.  Dysregulated phosphatidylinositol signaling promotes endoplasmic-reticulum-stress-mediated intestinal mucosal injury and inflammation in zebrafish , 2013, Disease Models & Mechanisms.

[55]  G. Goldman,et al.  Functional Characterization of an Aspergillus fumigatus Calcium Transporter (PmcA) that Is Essential for Fungal Infection , 2012, PloS one.

[56]  R. Zoeller,et al.  Thyroid health and the environment. , 2007, Thyroid : official journal of the American Thyroid Association.

[57]  Alexander F Schier,et al.  Behavioral screening for neuroactive drugs in zebrafish , 2012, Developmental neurobiology.

[58]  A. Riu,et al.  Identification of Estrogen Target Genes during Zebrafish Embryonic Development through Transcriptomic Analysis , 2013, PloS one.

[59]  C. Barata,et al.  Modeling mixtures of thyroid gland function disruptors in a vertebrate alternative model, the zebrafish eleutheroembryo. , 2013, Toxicology and applied pharmacology.

[60]  H. Yost,et al.  Cardiac morphology and blood pressure in the adult zebrafish , 2001, The Anatomical record.

[61]  S. Scholz.  Zebrafish embryos as an alternative model for screening of drug-induced organ toxicity , 2013, Archives of Toxicology.

[62]  D. Sarne.  Effects of the Environment, Chemicals and Drugs on Thyroid Function , 2016 .

[63]  Kevin M Crofton,et al.  Thyroid disrupting chemicals: mechanisms and mixtures. , 2008, International journal of andrology.

[64]  Raphaël Marée,et al.  Phenotype Classification of Zebrafish Embryos by Supervised Learning , 2012, PloS one.

[65]  E. Weinberg,et al.  Cloning and characterization of vascular endothelial growth factor (VEGF) from zebrafish, Danio rerio. , 1998, Biochimica et biophysica acta.

[66]  H. Spaink,et al.  Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling , 2013, Archives of Toxicology.

[67]  Dhwani K. Desai,et al.  Giant Hydrogen Sulfide Plume in the Oxygen Minimum Zone off Peru Supports Chemolithoautotrophy , 2013, PloS one.

[68]  L. Zon,et al.  Transparent adult zebrafish as a tool for in vivo transplantation analysis. , 2008, Cell stem cell.

[69]  Cheol‐Hee Kim,et al.  Fucoidan promotes mechanosensory hair cell regeneration following amino glycoside-induced cell death , 2011, Hearing Research.

[70]  A. Rubinstein,et al.  Zebrafish assays for drug toxicity screening , 2006, Expert opinion on drug metabolism & toxicology.

[71]  S. Andreescu,et al.  Loss of ascl1a prevents secretory cell differentiation within the zebrafish intestinal epithelium resulting in a loss of distal intestinal motility. , 2013, Developmental biology.

[72]  W. Heideman,et al.  Heart malformation is an early response to TCDD in embryonic zebrafish. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  N. Roy,et al.  Neurotoxicity assessment using zebrafish. , 2007, Journal of pharmacological and toxicological methods.

[74]  C. Ton,et al.  Zebrafish as a model for developmental neurotoxicity testing. , 2006, Birth defects research. Part A, Clinical and molecular teratology.

[75]  B. Padnos,et al.  Assessing locomotor activity in larval zebrafish: Influence of extrinsic and intrinsic variables. , 2011, Neurotoxicology and teratology.

[76]  I. Al-Zakwani,et al.  Gender-related differences in the presentation, management, and outcomes among patients with acute coronary syndrome from Oman. , 2011, Journal of the Saudi Heart Association.

[77]  L. Kunkel,et al.  Modeling human muscle disease in zebrafish. , 2007, Biochimica et biophysica acta.

[78]  K. Eagle,et al.  Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). , 2002 .

[79]  Peter D. Currie,et al.  Morphogenesis and Cell Fate Determination within the Adaxial Cell Equivalence Group of the Zebrafish Myotome , 2012, PLoS genetics.

[80]  Y. Hirose,et al.  Hair Cell Toxicity in Anti-cancer Drugs: Evaluating an Anti-cancer Drug Library for Independent and Synergistic Toxic Effects on Hair Cells Using the Zebrafish Lateral Line , 2011, Journal of the Association for Research in Otolaryngology.

[81]  Thomas A. Hawkins,et al.  A genetic screen identifies genes essential for development of myelinated axons in zebrafish. , 2006, Developmental biology.

[82]  S. Leach,et al.  In vivo imaging of zebrafish digestive organ function using multiple quenched fluorescent reporters. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[83]  Audrey White,et al.  Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. , 2007, Cancer research.

[84]  W. Heideman,et al.  Sox9b Is Required for Epicardium Formation and Plays a Role in TCDD-Induced Heart Malformation in Zebrafish , 2013, Molecular Pharmacology.

[85]  Leonard I. Zon,et al.  Organogenesis--Heart and Blood Formation from the Zebrafish Point of View , 2002, Science.

[86]  Demetrio Raldúa,et al.  Clofibrate and gemfibrozil induce an embryonic malabsorption syndrome in zebrafish. , 2008, Toxicology and applied pharmacology.

[87]  M. Pack,et al.  Intestinal growth and differentiation in zebrafish , 2005, Mechanisms of Development.

[88]  V. Sukhatme,et al.  Statin‐induced muscle damage and atrogin‐1 induction is the result of a geranylgeranylation defect , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  Hae-Chul Park,et al.  Visualization of myelination in GFP‐transgenic zebrafish , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[90]  Bing-Liang Ma,et al.  Pharmacokinetic properties, potential herb–drug interactions and acute toxicity of oral Rhizoma coptidis alkaloids , 2013, Expert opinion on drug metabolism & toxicology.

[91]  S. Neuhauss,et al.  Zebrafish (Danio rerio) neuromast: promising biological endpoint linking developmental and toxicological studies. , 2009, Aquatic toxicology.

[92]  A. Ghysen,et al.  Early efferent innervation of the zebrafish lateral line , 2001, The Journal of comparative neurology.

[93]  S. Baraban,et al.  Zebrafish as a model for studying genetic aspects of epilepsy , 2010, Disease Models & Mechanisms.

[94]  J. Wood,et al.  Contextual Compound Screening for Improved Therapeutic Discovery , 2013, ChemBioChem.

[95]  R. Bernardos,et al.  Vincristine and bortezomib cause axon outgrowth and behavioral defects in larval zebrafish , 2012, Journal of the peripheral nervous system : JPNS.

[96]  D. D. Brown,et al.  The role of thyroid hormone in zebrafish and axolotl development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[97]  Edwin W Rubel,et al.  Using the Zebrafish Lateral Line to Screen for Ototoxicity , 2008, Journal of the Association for Research in Otolaryngology.

[98]  M. Fishman,et al.  Vessel patterning in the embryo of the zebrafish: guidance by notochord. , 1997, Developmental biology.

[99]  T. Collier,et al.  Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. , 2004, Toxicology and applied pharmacology.

[100]  W. Heideman,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits regression of the common cardinal vein in developing zebrafish. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[101]  J. Boyer,et al.  A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease , 2005, Development.

[102]  C. ffrench-Constant,et al.  Individual axons regulate the myelinating potential of single oligodendrocytes in vivo , 2011, Development.

[103]  I. Al-Zakwani,et al.  Characteristics, management, and in-hospital outcomes of diabetic acute coronary syndrome patients in Oman. , 2010, Saudi medical journal.

[104]  Michael Tsang,et al.  Automated image‐based phenotypic analysis in zebrafish embryos , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[105]  Demetrio Raldúa,et al.  Simple, rapid zebrafish larva bioassay for assessing the potential of chemical pollutants and drugs to disrupt thyroid gland function. , 2009, Environmental science & technology.

[106]  M. Zubaid,et al.  Utilization and Determinants of In-Hospital Cardiac Catheterization in Patients With Acute Coronary Syndrome From the Middle East , 2010, Angiology.

[107]  I. Al-Zakwani,et al.  Prevalence, Characteristics, and In-Hospital Outcomes of Metabolic Syndrome Among Acute Coronary Syndrome Patients From Oman , 2011, Angiology.

[108]  N. Sylvain,et al.  Zebrafish embryos exposed to alcohol undergo abnormal development of motor neurons and muscle fibers. , 2010, Neurotoxicology and teratology.

[109]  M. Zubaid,et al.  Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE). , 2008, Saudi medical journal.

[110]  P. Hodson,et al.  AhR2-mediated, CYP1A-independent cardiovascular toxicity in zebrafish (Danio rerio) embryos exposed to retene. , 2011, Aquatic toxicology.

[111]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[112]  D. Raldúa,et al.  Zebrafish eleutheroembryos as an alternative system for screening chemicals disrupting the mammalian thyroid gland morphogenesis and function. , 2012, Reproductive toxicology.

[113]  P. Carmeliet,et al.  Genetics in zebrafish, mice, and humans to dissect congenital heart disease: insights in the role of VEGF. , 2004, Current topics in developmental biology.

[114]  Gareth J Waldron,et al.  Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery. , 2008, Journal of pharmacological and toxicological methods.

[115]  J. Russell,et al.  Recent advances in drug-induced neuropathies , 2002, Current opinion in neurology.

[116]  R. Franklin,et al.  Zebrafish myelination: a transparent model for remyelination? , 2008, Disease Models & Mechanisms.

[117]  Jin-jin Fan,et al.  Sodium benzoate exposure downregulates the expression of tyrosine hydroxylase and dopamine transporter in dopaminergic neurons in developing zebrafish. , 2009, Birth defects research. Part B, Developmental and reproductive toxicology.